LAVA Therapeutics N.V. (LVTX)
1.740
0.00 (0.00%)
Inactive · Last trade price on Nov 20, 2025
LAVA Therapeutics Employees
LAVA Therapeutics had 34 employees as of December 31, 2024. The number of employees decreased by 3 or -8.11% compared to the previous year.
Employees
34
Change (1Y)
-3
Growth (1Y)
-8.11%
Revenue / Employee
$146,765
Profits / Employee
-$681,853
Market Cap
45.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34 | -3 | -8.11% |
| Dec 31, 2023 | 37 | -32 | -46.38% |
| Dec 31, 2022 | 69 | 11 | 18.97% |
| Dec 31, 2021 | 58 | 27 | 87.10% |
| Dec 31, 2020 | 31 | - | - |
LVTX News
- 14 days ago - LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq - GlobeNewsWire
- 17 days ago - LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline - GlobeNewsWire
- 2 months ago - LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - GlobeNewsWire
- 3 months ago - LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - LAVA Reports First Quarter 2025 Financial Results, Provides Business Update - GlobeNewsWire
- 8 months ago - LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation - GlobeNewsWire
- 8 months ago - LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 9 months ago - Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang - Benzinga